1 / 15

FSIS Risk Management Plan For Listeria monocytogenes

FSIS Risk Management Plan For Listeria monocytogenes. Daniel Engeljohn, Ph.D. Executive Associate Policy Analysis and Formulation. Risk Management. FSIS follow-up to 2001 HHS/USDA Joint Action Plan Issued a proposed rule February 27, 2001 Held public meetings

Download Presentation

FSIS Risk Management Plan For Listeria monocytogenes

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. FSISRisk Management PlanFor Listeria monocytogenes Daniel Engeljohn, Ph.D. Executive Associate Policy Analysis and Formulation

  2. Risk Management • FSIS follow-up to 2001 HHS/USDA Joint Action Plan • Issued a proposed rule • February 27, 2001 • Held public meetings • 3 meetings designed to clarify effective controls • Issued a new directive • Focused on high-risk product controls • Caused industry sharing of plant-generated data

  3. Risk Management • Joint Action Plan (continued) • In 2003, FSIS issued • In-plant risk assessment • Interim final rule • 5 workshops • New compliance guidelines • New inspection procedures

  4. Risk Management • Interim Final Rule Effectiveness • Change in industry practices • Rigor of lethality, growth suppression, and sanitation • Risk-based verification – focus on high risk products and operations

  5. Risk Management • Interim Final Rule Effectiveness(continued) • Training of inspection personnel • Prevalence changes in groups of products • Use of labeling claims

  6. Risk Management • Interim Final Rule Effectiveness(continued) • Compliance guidelines for small plants • Public health impact • Attribution of illness for meat, poultry, and processed eggs (FoodNet case-control study)

  7. Risk Management • Interim Final Rule Effectiveness(continued) • Distribution concerns – retail, growth • State program activities • Education and outreach

  8. Risk Communication • FDA/FSIS risk ranking and FSIS risk assessment have informed risk communication activities • FSIS has worked closely with FDA to ensure that messages for consumers are consistent.

  9. Consumer Advice • Based on the the scientific information available today, consumer advice on L. monocytogenes that we provide to at-risk populations will remain the same…

  10. Consumer Advice • Advice regarding meat and poultry products remains as follows: • Do not eat hot dogs, luncheon meats, or deli meats unless they are reheated until steaming hot • Do not eat refrigerated pâté or meat spreads. Canned or shelf-stable pâté and meat spreads can be eaten

  11. Consumer Advice • Because L. monocytogenes can grow at refrigeration temperatures of 40 ºF or below, FSIS joins FDA in advising all consumers to: • Use perishable items that are precooked or ready-to-eat as soon as possible • Clean refrigerators regularly • Use a refrigerator thermometer to make sure that the refrigerator always stays at 40 º F or below

  12. Outreach • FSIS continues to target at-risk populations with its consumer messages, including the elderly, pregnant women and individuals with weakened immune systems

  13. Outreach • FSIS is increasing outreach to these groups in a variety of ways • Food safety messages are included in patient education videos shown in doctors' waiting rooms • Expanding efforts to reach medical centers that treat organ transplant patients • USDA Food Safety Mobile

  14. Future Directions • As industry makes further strides in reducing levels of L. monocytogenes in ready-to-eat products, and as more information is gathered regarding consumer behavior, FSIS will re-evaluate whether changes in consumer advice are warranted

  15. Future Directions (continued) • FSIS expects to: • Refine its risk-based verification activities to enhance public health protection at the points in the farm-to-table continuum where mitigation is most effective • Continue to work closely with FDA and CDC to reduce the burden of human illnesses caused by L. monocytogenes infections

More Related